fluorodeoxyglucose f18 has been researched along with Cardiac Output, Low in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mortensen, PT; Rehling, M; Wiggers, H | 1 |
| Bonser, RS; Camici, PG; Dutka, DP; Gathercole, D; Mongillo, M; Pagano, D; Pitt, M | 1 |
| Inoue, N; Inoue, T; Ishikawa, T; Kimura, K; Kobayashi, T; Matsumoto, K; Matsushita, K; Shimura, M; Sumita, S; Taima, M; Takahashi, N; Uchino, K; Umemura, S | 1 |
| Hasegawa, S; Hirata, M; Hori, M; Nishimura, T; Tokita, N; Yamaguchi, H; Yoshioka, J | 1 |
4 other study(ies) available for fluorodeoxyglucose f18 and Cardiac Output, Low
| Article | Year |
|---|---|
Selection of heart failure patients for cardiac resynchronisation therapy: a role for PET?
Topics: Cardiac Output, Low; Cardiac Pacing, Artificial; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Patient Selection; Positron-Emission Tomography; Prognosis; Risk Assessment; Risk Factors; Treatment Outcome | 2007 |
Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease.
Topics: Aged; Blotting, Western; Cardiac Output, Low; Coronary Artery Disease; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 4; Humans; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2006 |
Reverse perfusion-metabolism mismatch predicts good prognosis in patients undergoing cardiac resynchronization therapy: a pilot study.
Topics: Aged; Cardiac Output, Low; Female; Fluorodeoxyglucose F18; Heart Septum; Humans; Male; Middle Aged; Pacemaker, Artificial; Perfusion; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2007 |
Fluorine-18 FDG myocardial positron emission tomographic findings before and after pituitary adenoma resection in a patient with acromegalic cardiomyopathy.
Topics: Acromegaly; Adenoma; Cardiac Output, Low; Cardiomyopathy, Hypertrophic; Fluorodeoxyglucose F18; Follow-Up Studies; Gated Blood-Pool Imaging; Glucose; Heart; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Myocardium; Pituitary Neoplasms; Preoperative Care; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Ventricular Function, Left | 2000 |